ERG and cancer: As the 5q21 (CHD1) deletion is mainly occurring in ERG fusion‐negative cancers [32], we next analyzed PSA recurrence in the subsets of 5q21‐normal (n = 5835) vs. 5q21‐deleted (n = 658) patients.